Gene · 6383
Papers4,416
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,416
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altering heparan sulfate suppresses cell abnormalities and neuron loss in Drosophila presenilin model of Alzheimer Disease. | iScience | 2024 | 39109174 | PubTator, text mining | PubMed |
| Glycolysis-related five-gene signature correlates with prognosis and immune infiltration in gastric cancer. | World J Gastrointest Oncol | 2024 | 39072176 | PubTator, text mining | PubMed |
| [Study on the application value of fecal SDC2 gene methylation detection in colorectal cancer screening of urban residents in Zengcheng District in Guangzhou City]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2024 | 39034786 | PubTator, text mining | PubMed |
| Correlation of syndecan gene amplification with metastatic potential and clinical outcomes in carcinomas. | Am J Physiol Cell Physiol | 2024 | 38953842 | PubTator, text mining | PubMed |
| Fine-tuning of liposome integrity for differentiated transcytosis and enhanced antitumor efficacy. | J Control Release | 2024 | 38866244 | PubTator, text mining | PubMed |
| Internalization of PEI-based complexes in transient transfection of HEK293 cells is triggered by coalescence of membrane heparan sulfate proteoglycans like Glypican-4. | Biomed Pharmacother | 2024 | 38850653 | PubTator, text mining | PubMed |
| Galectin-3-Binding Protein Inhibits Extracellular Heparan 6-O-Endosulfatase Sulf-2. | Mol Cell Proteomics | 2024 | 38825040 | PubTator, text mining | PubMed |
| Enhancement of HSV-1 cell-free virion release by the envelope protein gC. | Virology | 2024 | 38805801 | PubTator, text mining | PubMed |
| A Conditionally Activated Cytosol-Penetrating Antibody for TME-Dependent Intracellular Cargo Delivery. | Antibodies (Basel) | 2024 | 38804305 | PubTator, text mining | PubMed |
| Benzene with Alkyl Chains Is a Universal Scaffold for Multivalent Virucidal Antivirals. | ACS Cent Sci | 2024 | 38799657 | PubTator, text mining | PubMed |
| Heparanase Stimulation of Physiologic Cardiac Hypertrophy Is Suppressed After Chronic Diabetes, Resulting in Cardiac Remodeling and Dysfunction. | Diabetes | 2024 | 38771953 | PubTator, text mining | PubMed |
| Heparan sulfate proteoglycans: Mediators of cellular and molecular Alzheimer's disease pathogenic factors via tunnelling nanotubes? | Mol Cell Neurosci | 2024 | 38750678 | PubTator, text mining | PubMed |
| Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations. | J Transl Med | 2024 | 38750573 | PubTator, text mining | PubMed |
| Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection. | Breast Cancer Res | 2024 | 38745208 | PubTator, text mining | PubMed |
| Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis. | J Med Life | 2024 | 38737656 | PubTator, text mining | PubMed |
| Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B. | Curr Hepatol Rep | 2024 | 38699562 | PubTator, text mining | PubMed |
| Syndecans, Exostosins and Sulfotransferases as Potential Synovial Inflammation Moderators in Patients with Hip Osteoarthritis. | Int J Mol Sci | 2024 | 38674142 | PubTator, text mining | PubMed |
| Real-World Stool-Based Syndecan-2 Methylation Test Improved Detection of Advanced Colorectal Neoplasia for Colorectal Cancer Screening: A Prospective, Multicenter, Community-Based Study. | Gastroenterology | 2024 | 38670282 | PubTator, text mining | PubMed |
| Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population. | World J Gastrointest Oncol | 2024 | 38660655 | PubTator, text mining | PubMed |
| The potency of mesenchymal stem/stromal cells: does donor sex matter? | Stem Cell Res Ther | 2024 | 38644508 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6383/papers?page=10